Edwards Lifesciences Working Capital Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 139.40  2.94  2.07%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Working Capital of Edwards Lifesciences Corporation with missing and latest data points interpolated. Working capital measures the difference between Current Assets and Current Liabilities.

1.57 B

            10 Years Trend  
Slightly volatile
 Working Capital 

Edwards Lifesciences Working Capital Over Time

2016-12-31  1,707,500,000 
2017-12-31  1,707,500,000 
2018-12-31  1,571,700,000 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  1,043,230,769
Geometric Mean  801,585,032
Coefficient Of Variation  58.41
Mean Deviation  536,033,136
Median  944,500,000
Standard Deviation  609,361,928
Range  1,697,600,000
R Value  0.95
R Squared  0.90
Significance  0.00000062
Slope  148,760,989

Currently Trending

Purchased over 500 shares of
few hours ago ago
Traded for 5.25
Purchased over 70 shares of
few hours ago ago
Traded for 34.98
Purchased over 30 shares of
few hours ago ago
Traded for 92.89